← Back to headlines
GENESIS Pharma Expands Partnership with Alnylam to Nordic Markets
GENESIS Pharma is extending its collaboration with Alnylam Pharmaceuticals by adding Denmark, Finland, Norway, and Sweden to their existing partnership, which already covers 13 Southeast European markets.
19 Jun, 08:57 — 19 Jun, 08:57
